Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine

With advances in the discovery of the clinical and molecular landscapes of prostate cancer (PCa), implementation of precision medicine-guided therapeutic testing in the clinic has become a priority. Patient derived organoids (PDOs) are three-dimensional (3D) tissue cultures that promise to enable th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pamarthy, Sahithi, Sabaawy, Hatem E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480086/
https://www.ncbi.nlm.nih.gov/pubmed/34587953
http://dx.doi.org/10.1186/s12943-021-01426-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480086/
https://www.ncbi.nlm.nih.gov/pubmed/34587953
http://dx.doi.org/10.1186/s12943-021-01426-3

Ejemplares similares